{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-092089","form_type":"8-K","ticker":"ATNM","cik":"0001388320","company_name":"Actinium Pharmaceuticals, Inc.","filed_at":"2023-12-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.829444+00:00","generated_at":"2026-06-07T19:16:39.626074+00:00","sec_items":["5.02","5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Actinium shareholders re-elect Nicholson, Steinhart as Class I directors; Marcum LLP ratified as auditor","bullets":["David Nicholson re-elected: 3,959,659 for, 3,275,844 withheld, 9,087,835 broker non-votes.","Richard Steinhart re-elected: 5,630,379 for, 1,777,251 withheld, 9,087,835 broker non-votes.","Marcum LLP ratified as independent auditor for FY2023: 15,842,146 for, 372,774 against, 280,545 abstain.","No other matters voted on at the November 30, 2023 annual meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-092089","json":"https://secwatch.observer/filing/0001213900-23-092089.json","markdown":"https://secwatch.observer/filing/0001213900-23-092089.md","text":"https://secwatch.observer/filing/0001213900-23-092089.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1388320/000121390023092089/0001213900-23-092089-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1388320/000121390023092089/ea189365-8k_actinium.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T19:16:39.626074+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2d0a353be5121ef59f94d7a5cc24e3b784960313","claim":"Actinium Pharmaceuticals, Inc. shareholders approved Election of David Nicholson and Richard I. Steinhart as Class I directors.","evidence_excerpt":"Director For Withhold Broker Non-Votes David Nicholson 3,959,659 3,275,844 9,087,835 Richard I. Steinhart 5,630,379 1,777,251 9,087,835","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390023092089/0001213900-23-092089-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"},{"claim_id":"abea647e3b934bd979a210c16ec679e2876c5bc9","claim":"Actinium Pharmaceuticals, Inc. shareholders approved Ratification of appointment of Marcum LLP as independent registered public accounting firm for fiscal year ending December 31, 2023.","evidence_excerpt":"For Against Abstain Broker Non-Votes 15,842,146 372,774 280,545 N/A","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390023092089/0001213900-23-092089-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}